Hormone therapy for menopause is safer than doctors had previously thought, new research says. It may also bring unexpected ...
With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some patients are reporting delays in filling prescriptions for estrogen patches.
As more women seek hormone replacement therapy, or HRT, the shortage of estrogen patches increases, forcing them to look for ...
KTVU FOX 2 on MSN
There's a shortage of estrogen patches. Here's what's leading to the problem and what women can do
An increasing number of women who use estrogen patches to help deal with perimenopause and menopause symptoms have been ...
With the removal of the black-box warning on hormone therapy for menopause, some providers and patients report shortages or delays, waiting for a pharmacy to restock transdermal estrogen patches.
The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded ...
The non-hormonal daily pill could benefit 500,000 women for whom HRT is not suitable.
While the treatment is primarily used for symptoms associated with menopause in women, it has also had its fair share of ...
Add Yahoo as a preferred source to see more of our stories on Google. McKinsey Jordan/Stocksy Ten years ago, if you had told me that I’d become the founder of a menopause company, I wouldn’t have ...
Women who start hormone replacement therapy (HRT) within a year after menopause may have a lower risk of developing osteoporosis, according to research presented at the American Academy of Orthopaedic ...
Menopause occurs when people assigned female at birth stop having menstrual periods and can no longer get pregnant. During the years leading up to menopause, known as perimenopause, the ovaries start ...
KLAS Las Vegas on MSN
Estrogen therapy warning removed: what this means for women
After 23 years, the FDA removed a major warning on estrogen therapy. Estrogen therapy carried a “black box” warning about breast cancer and heart risk, but as of February 12, the FDA removed the broad ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果